{
  "docId": "019de071-dd7f-730a-8977-e46a36e30dcf",
  "docSlug": "abc22aebd2d55a5159142df321cabcee",
  "documentTitle": "Bionomics | IPO Presentation Deck | 38 slides",
  "authorId": "bionomics",
  "authorName": "Bionomics",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investment_bank",
  "sourceTypeLabel": "Investment bank",
  "presentationDate": "2021-12-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7391304,
  "pageNumber": 14,
  "pageCount": 38,
  "prevPage": 13,
  "nextPage": 15,
  "slideType": "why_now",
  "function": "argue_timing",
  "density": "dense",
  "nDataPoints": 4,
  "notes": "Includes a pharmacokinetic chart showing concentration vs time for different doses.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de071-dd7f-730a-8977-e46a36e30dcf/14",
  "deckHref": "/decks/019de071-dd7f-730a-8977-e46a36e30dcf",
  "deckJsonHref": "/decks/019de071-dd7f-730a-8977-e46a36e30dcf.json",
  "deckAnchorHref": "/decks/019de071-dd7f-730a-8977-e46a36e30dcf#slide-14",
  "components": [
    {
      "bbox": {
        "h": 0.4,
        "w": 0.15,
        "x": 0.5,
        "y": 0.45
      },
      "kind": "callout",
      "text": "Maximum concentrations reached in ~45 – 105 min. across the dose range",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1d8c585c-e5f6-4f3e-b0c8-0f5fe04a4bfc",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.4,
        "w": 0.3,
        "x": 0.65,
        "y": 0.45
      },
      "kind": "chart",
      "text": "Concentration versus Time chart showing 300mg, 600mg, 900mg, and 1200mg tablet fasted data.",
      "attrs": null,
      "subkind": "line",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f1a767fd-045a-4cda-85be-d12feb6f532f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.4,
        "x": 0.15,
        "y": 0.9
      },
      "kind": "disclaimer",
      "text": "*Based on path of CNS peer proceeding with registrational Phase 3 endpoint",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "30c5b90f-a818-4190-b809-53ff9f3d4364",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.45,
        "x": 0.5,
        "y": 0.15
      },
      "kind": "list",
      "text": "Rapid Onset of Action with BNC210 Formulation: Clinically demonstrated potential for reducing anxiety; Observed acute anxiolytic efficacy similar to lorazepam without sedative properties; Formulation well-suited for acute dosing.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "50021ed2-d768-4a08-b32d-93ded6e26a37",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.6,
        "w": 0.4,
        "x": 0.05,
        "y": 0.15
      },
      "kind": "list",
      "text": "Emerging Regulatory Landscape & Unmet Need: No fast-acting FDA-approved medications for as-needed treatment of SAD; Benzodiazepines prescribed off-label have significant side effects; Growing unmet need; FDA precedent on simplified public speaking challenge endpoint.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9c9d807a-0edb-478d-8cb1-32329ade5c2f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.8,
        "x": 0.05,
        "y": 0.03
      },
      "kind": "title",
      "text": "BNC210's Rapid Onset of Action is Potentially Well-Positioned for Social Anxiety Disorder",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "94298c2d-5c85-4cf8-b034-d09dc0d9add9",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [
    {
      "to": 14,
      "from": 14,
      "name": "Why Now",
      "slug": "15-why-now",
      "bestFor": "Sales pitches, fundraising, requesting immediate budget approval",
      "matchId": "79e365d7-659e-492f-96a2-b9cf6b7e592d",
      "evidence": "Slide 14 presents BNC210's rapid onset of action",
      "position": 1,
      "objective": "Why is now the right time for BNC210?",
      "structure": "The Context (Trends) -> The Trigger Event -> The Window of Opportunity",
      "confidence": 0.6,
      "description": "Create temporal urgency by proving that the window of opportunity is opening or closing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}